SCHEMBL4646104

SCHEMBL4646104

Cc1ccc(N=C(S)C=CSc2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.50
ALDH1A1 P00352 6/20 0.50
NPSR1 Q6W5P4 4/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
LMNA P02545 3/20 0.50
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50
RELA Q04206 2/20 0.50
HPGD P15428 2/20 0.41
PLIN1 O60240 1/20 0.41
HTT P42858 1/20 0.41
PLIN5 Q00G26 1/20 0.41
ABHD5 Q8WTS1 1/20 0.41
CYP2D6 P10635 2/20 0.38
HIF1A Q16665 1/20 0.38
HTR3E A5X5Y0 2/20 0.37
HTR3B O95264 2/20 0.37
HTR3A P46098 2/20 0.37
HTR3D Q70Z44 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4645596 0.94 MAPT (0.54) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL4647027 0.92 MAPT (0.46) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL4647344 0.89 LMNA (0.47) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL4647110 0.85 MAPT (0.41) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL4646659 0.85 MEN1 (0.41) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL4647939 0.85 ALDH1A1 (0.41) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL4648033 0.85 ALDH1A1 (0.41) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL4646000 0.85 ALDH1A1 (0.54) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL4648580 0.84 LMNA (0.38) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL4645544 0.84 ALDH1A1 (0.39) MAPTALDH1A1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410316-B2 Iminopropene compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-02 US disclosed
US-20110319437-A1 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-29 US disclosed
EP-1957459-A2 IMINOPROPENE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-08-20 EP disclosed
WO-2007063702-A2 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319437-A1 IMINOPROPENE COMPOUND AND USE THEREOF IMPA1, INPP5A, CTRL MAPT 2992/4885ALDH1A1 2213/4885NPSR1 3777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.